Millions Logo
home>US Stocks>Seer - Class A
SEER
Seer - Class AHealthcare
$1.57$-0.50 (-24.30%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $1.5552 Week High: $2.38

Seer - Class A Share Price Today

Seer - Class A opened higher at $1.60, compared with its previous close of $1.59. In the last trading session, the stock traded between $1.56 and $1.65. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in Seer - Class A is now worth

$ 5.34

Resulting in a loss of

$ 94.66 (94.66%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 1 Analysts

Buy
100%
Hold
0%
Sell
0%

Markets Today

Today's Change

$-0.02 (-1.45%)

Day High

$1.65

Day Low

$1.56

Day Open

$1.60

Prev Close

$1.59

Volume

55,596

1W Return

-8.04%

1M Return

-26.95%

3M Return

-27.95%

6M Return

-14.37%

1Y Return

-24.30%

Fundamentals

Market Cap ($ Mn)

87

PE Ratio

-

PB Ratio

0.49

PEG Ratio

-

ROE

-25.24%

ROCE

-27.05%

EPS (TTM)

$-0.31

Investment Returns

1 Week

-8.04%

1 Month

-26.95%

3 Months

-27.95%

6 Months

-14.37%

9 Months

-17.96%

Financials

Quarterly
All values in $ Mn
4.1

Mar 25
3.9

Jun 25
4.0

Sep 25
4.1

Dec 25
2.7

Mar 26
3.0

Jun 26

Updates

11Nov

Seer cuts FY26 revenue guidance to $13.5M-$14.5M on sales delays

Full-year 2026 revenue guidance cut to $13.5M-$14.5M from $16M-$18M. Q3 revenue rose to $4 million from $3.1 million in Q2. Gross margin declined 130 bps sequentially to 47%. Operating expenses fell 23% YoY to $16.5 million. Cash position stands at $198 million after share repurchases.

2 days ago
22Oct

Seer Inc. to report Q3FY26 results on November 10

Seer Inc. will report Q3 2026 financial results on November 10, 2026. Conference call scheduled for 4:30 pm Eastern Time. Webcast available via investor.seer.bio with archived replay later.

22 days ago
23Sep

Seer to present PRECISE-SG100K proteomics findings at HUPO 2026

Seer Inc. and Nanyang Technological University will present early findings from the PRECISE-SG100K study at HUPO 2026. The study includes a 10,000-participant arm using Seer's Proteograph Product Suite for deep proteomic profiling. Proteograph increases protein coverage depth by 7 to 10-fold compared to direct plasma analysis. Seer's technology has been utilized in over 100 peer-reviewed scientific publications to date.

1mo ago
21Sep

Seer CFO David Horn to depart Oct 1; Endweiss succeeds

Seer CFO David Horn departs October 1, 2026. Charles Endweiss succeeds as principal financial officer. Endweiss joins from VP of FP&A role since Jan 2021. Horn leaves for private company opportunity.

1mo ago
4Sep

Radoff-JEC Group Calls on Meeta Gulyani to Resign from Seer Board

Radoff-JEC Group owns ~7.7% of Seer, Inc. shares. Open letter demands immediate resignation of director Meeta Gulyani. Cites lack of public board experience since Nov 2021 appointment. Notes market cap fell from $1.5 billion to $100 million (>90% drop). Criticizes passive role on Special Committee regarding acquisition proposals.

2mo ago
13Aug

Radoff-JEC Group urges Seer board to accept private sale offers

Radoff-JEC Group, holding 7.7% of Seer Inc., demands the board accept private sale offers after Q2 2026 results showed revenue of $3.1M and a net loss of $16.9M. The group criticizes the Special Committee's engagement and cites CEO Omid Farokhzad's prior admission that the company should not remain public.

3mo ago

Similar Stocks

StockLTPChange %Market CapPE
$547.03-0.16%$1,38,692.89M31.55
$61.05+0.38%$1,31,510.31M14.39
$248.69-0.85%$1,00,625.20M-
$959.41+4.73%$97,505.80M19.64
$977.58+0.62%$61,476.10M38.99
$419.98-0.95%$46,108.31M65.60
$180.70-6.40%$39,083.96M-
$53.87-0.37%$33,618.11M26.24
$70.01+0.81%$31,173.07M32.37
$41.85+1.60%$30,322.88M-
$120.75+1.05%$26,490.14M-
$122.27+1.64%$24,922.54M15.85